The framework agreement will be executed by issuing purchase orders.
Each lot will be the subject of a separate allocation.
The services are regulated by unit prices.
Supply of pharmaceutical products: medicines and pourable fluids
A10bh01 - Sitagliptin alone and in combinationA10bh01 - Sitagliptin alone and in combination
S01la04 - Ranibizumab 10 mg/mlS01la04 - Ranibizumab 10 mg/ml
A04ad05 - Metopimazine Oral LyophilisateA04ad05 - Metopimazine Oral Lyophilisate
L01ad01 - CarmustineL01ad01 - Carmustine
L04aa25 - Eculizumab - Indication for paroxysmal nocturnal hemoglobinuriaL04aa25 - Eculizumab - Indication for paroxysmal nocturnal hemoglobinuria
A16ax07 - SapropterinA16ax07 - Sapropterin
L04aa31 - Tablet teriflunomideL04aa31 - Tablet teriflunomide
B01ac11 - Iloprost injectableB01ac11 - Iloprost injectable
C01dx12 - MolsidomineC01dx12 - Molsidomine
L01bc01 - Cytarabine for Iv and Sc ChannelsL01bc01 - Cytarabine for Iv and Sc Channels
M02aa15 - Ains - Gel for local useM02aa15 - Ains - Gel for local use
M03ac04 - Atracurium 250 mgM03ac04 - Atracurium 250 mg
N03ax15 - ZonisamideN03ax15 - Zonisamide
N03ax18 - Lacosamide injectableN03ax18 - Lacosamide injectable
N03ax19 - Lacosamide TabletsN03ax19 - Lacosamide Tablets